Kaposi's sarcoma patients in the Swiss HIV Cohort Study with and without detectable human herpesvirus 8 in peripheral blood mononuclear cells.
Kaposi's sarcoma patients in the Swiss HIV Cohort Study with and without detectable human herpesvirus 8 in peripheral blood mononuclear cells.
复制标题
瑞士 HIV 队列研究中的卡波西肉瘤患者外周血单核细胞中检测到或未检测到人类疱疹病毒 8。
DOI:
10.1097/00002030-199715000-00021
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
Vernazza,PL
中科院分区:
文献类型:
--
作者:
Quinlivan,EB;Ye,D;Wehbie,RS;Stewart,PW;Flepp,M;Vernazza,PL
Human herpesvirus (HHV)-8 DNA is detectable in peripheral blood samples of some but not all patients with Kaposi's sarcoma (KS)[1, 2]. Because HHV-8 is present in virtually all KS lesions [3–7], it is not clear why only 50% of the patients have detectable amounts of HHV-8 DNA in peripheral blood mononuclear cells (PBMC). We used polymerase chain reaction (PCR) to detect HHV-8 DNA in PBMC from KS patients in the Swiss HIV Cohort to address this question [8].PCR was performed on stored serial PBMC (Fig. 1a) using nested minor capsid and protease PCR assays [9]. Eleven samples had detectable HHV-8 DNA using DNA from 6× 10 4 PBMC. Four samples had detectable HHV-8 DNA after increasing the input DNA threefold. One sample (patient 4) was repeatedly positive by minor capsid PCR assay, although the protease PCR assay could not confirm the results. Therefore, nine (45%) of the 20 patients with KS had HHV-8 DNA that was detectable in their peripheral blood. Of these nine patients, eight were positive at the initial sample visit (median, 15 months prior to KS diagnosis). The only patient with a documented conversion from undetectable to detectable HHV-8 DNA did so 11–18 months before the diagnosis of KS.